The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy.

Francesca CastellaniAndrea VisentinMarta CampagnoloAlessandro SalvalaggioMario CacciavillaniCinzia CandiottoRoberta BertorelleLivio TrentinChiara Briani

Published in: Neurology(R) neuroimmunology & neuroinflammation (2020)

This study provides Class IV evidence that for patients with anti-MAG antibody neuropathy, ibrutinib improves neuropathy symptoms.

Keyphrases

chronic lymphocytic leukemia
depressive symptoms
sleep quality